Speciality Medicines IPO vs Wildnet Technologies IPO
Comparison between Speciality Medicines IPO and Wildnet Technologies IPO.
IPO Details
Speciality Medicines IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Wildnet Technologies IPO is a SME Bookbuilding proposed to list at BSE SME.
The total issue size of Speciality Medicines IPO is up to ₹27.28 Cr whereas the issue size of the Wildnet Technologies IPO is up to ₹0.00 Cr. The final issue price of Speciality Medicines IPO is ₹124.00 per share and of Wildnet Technologies IPO is .
Speciality Medicines IPO opens on Mar 20, 2026, while Wildnet Technologies IPO opens on . The closing date of Speciality Medicines IPO and Wildnet Technologies IPO is Mar 24, 2026, and , respectively.
In the Speciality Medicines IPO Retail Individual Investors (RII) are offered 10,90,000 shares while in Wildnet Technologies IPO retail investors are offered 10,90,000 shares. Qualified Institutional Buyers (QIB) are offered 21,000 shares in Speciality Medicines IPO and in Wildnet Technologies IPO.